AI-generated summary
The authors pooled 15 randomised trials of low-level laser therapy for chronic non-specific low back pain, involving 1039 participants. They report short-term pain reduction favouring laser over sham, seen only with higher doses (at least 3 J per point) and in people with shorter pain duration. The authors rate the evidence as moderate quality and call for more rigorously blinded trials.
- Participants
- 1,039
- Studies included
- 15
- Who or what was studied
- Adults with chronic non-specific low back pain
- Limits stated in the abstract
- The authors note that trial data were insufficient and that greater certainty requires rigorously blinded trials using appropriate laser dosage.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Meta-analysis, Dose, GRADE, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.